Industry NewsAlmac Supports Clients in Response to New, Stringent, FDA Heavy Metal Mandates by Investing in ICP-MS Equipment
Product NewsGenomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
Product NewsAlmac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration